Peter Ax

Peter Ax, Founder & CEO of UpScriptHealth, dives into how tariffs affect both branded and generic medications. He highlights potential shifts in U.S. manufacturing and strategic supply chain adjustments due to these tariffs. The discussion also emphasizes the role of digital health platforms in reducing costs and improving patient care through telehealth. Ax shares insights on forging partnerships to enhance medication accessibility and the need for innovation to rebuild trust between pharma and patients.